Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (68 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Canara Robeco ELSS Tax Saver |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹100.90 |
| 12 Apr 2015 | ₹164.92 |
| 31 May 2016 | ₹150.90 |
| 19 Jul 2017 | ₹189.97 |
| 07 Sep 2018 | ₹208.33 |
| 27 Oct 2019 | ₹197.21 |
| 15 Dec 2020 | ₹222.21 |
| 03 Feb 2022 | ₹287.92 |
| 25 Mar 2023 | ₹270.56 |
| 12 May 2024 | ₹359.28 |
| 01 Jul 2025 | ₹404.99 |
| 20 Aug 2026 | ₹396.56 |
| Metric | Canara Robeco · Direct · IDCW NAV ₹79.47 Very High risk ★★☆☆☆ | Category median ELSS · 68 funds |
|---|---|---|
| -1.24% | +2.22% | |
| +8.26% | +9.76% | |
| +7.31% | +8.88% | |
| +9.27% | +10.68% | |
| +10.64% | +10.64% | |
| +6.92% | — | |
| +11.19% | +11.55% | |
| +10.86% | +12.14% | |
| +10.98% | +10.94% | |
| Risk | ||
| 14.03% | 14.08% | |
| 0.13 | 0.32 | |
| 0.17 | 0.44 | |
| -37.85% | -35.52% | |
| Nifty 500 | — | |
| -3.09% | -1.42% | |
| 0.94 | 0.96 | |
| 92.3% | 91.4% | |
| 109.7% | 94.7% | |
| 0.70% | 1.17% | |
| ₹8,491Cr | ₹694.87Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 33% | 33% | |
| Shridatta Bhandwaldar | — | |
| 02 Jan 2013 | — | |
| 74 | — | |
| 38.3% | — | |
| 3.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.